Differential regulation of MHC II and invariant chain expression during maturation of monocyte-derived dendritic cells

Journal of Leukocyte Biology

Volumn 91, Issue 5, 2012, Pages 729-737

  Bakke, Oddmund ^a,b   Landsverk, Ole J B ^a   Ottesen, Anett H ^a   Berg Larsen, Axel ^a   Appel, Silke ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

CD74; DC maturation; Ii translation transport half life degradation

Indexed keywords

II PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; DENDRITIC CELL; HUMAN; HUMAN CELL; MONOCYTE DERIVED DENDRITIC CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOPRECIPITATION; MONOCYTES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 84860894205     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0311150     Document Type: Article

References (56)

1. Trowsdale, J., Ragoussis, J., Campbell, R. D. (1991) Map of the human MHC. Immunol. Today 12, 443-446.
2. Cresswell, P. (1994) Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12, 259-293.
3. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B., Palucka, K. (2000) Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811.
4. Reis e Sousa, C. (2006) Dendritic cells in a mature age. Nat. Rev. Immunol. 6, 476-483.
5. Van Niel, G., Wubbolts, R., Stoorvogel, W. (2008) Endosomal sorting of MHC class II determines antigen presentation by dendritic cells. Curr. Opin. Cell Biol. 20, 437- 444.
6. Villadangos, J. A., Schnorrer, P., Wilson, N. S. (2005) Control of MHC class II antigen presentation in dendritic cells: a balance between creative and destructive forces. Immunol. Rev. 207, 191-205.
7. Kampgen, E., Koch, N., Koch, F., Stoger, P., Heufler, C., Schuler, G., Romani, N. (1991) Class II major histocompatibility complex molecules of murine dendritic cells: synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture. Proc. Natl. Acad. Sci. USA 88, 3014-3018.
8. Villadangos, J. A., Cardoso, M., Steptoe, R. J., van Berkel, D., Pooley, J., Carbone, F. R., Shortman, K. (2001) MHC class II expression is regulated in dendritic cells independently of invariant chain degradation. Immunity 14, 739-749.
9. Cella, M., Engering, A., Pinet, V., Pieters, J., Lanzavecchia, A. (1997) Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388, 782-787.
10. Wilson, N. S., El-Sukkari, D., Villadangos, J. A. (2004) Dendritic cells con-stitutively present self antigens in their immature state in vivo and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis. Blood 103, 2187-2195.
11. Pure, E., Inaba, K., Crowley, M. T., Tardelli, L., Witmer-Pack, M. D., Ruberti, G., Fathman, G., Steinman, R. M. (1990) Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain. J. Exp. Med. 172, 1459-1469.
12. Rescigno, M., Citterio, S., Thery, C, Rittig, M., Medaglini, D., Pozzi, G., Amigorena, S., Ricciardi-Castagnoli, P. (1998) Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells. Proc. Natl. Acad. Sci. USA 95, 5229-5234.
13. Landmann, S., Muhlethaler-Mottet, A., Bernasconi, L., Suter, T., Wald-burger, J. M., Masternak, K, Arrighi, J. F., Hauser, C, Fontana, A., Reith, W. (2001) Maturation of dendritic cells is accompanied by rapid transcriptional silencing of class II transactivator (CIITA) expression.J. Exp. Med. 194, 379-391.
14. LeibundGut-Landmann, S., Waldburger, J. M., Krawczyk, M., Otten, L. A, Suter, T., Fontana, A, Acha-Orbea, H., Reith, W. (2004) Mini-review: specificity and expression of CIITA, the master regulator of MHC class II genes. Eur. J. Immunol. 34, 1513-1525.
15. Wright, K. L., Ting, J. P. (2006) Epigenetic regulation of MHC-II and CIITA genes. Trends Immunol. 27, 405-412.
16. Krawczyk, M., Seguin-Estevez, Q., Leimgruber, E., Sperisen, P., Schmid, C, Bucher, P., Reith, W. (2008) Identification of CIITA regulated genetic module dedicated for antigen presentation. PLoS Genet. 4, e1000058.
17. O'Sullivan, D. M., Noonan, D., Quaranta, V. (1987) Four Ia invariant chain forms derive from a single gene by alternate splicing and alternate initiation of transcription/translation. J. Exp. Med. 166, 444-460.
18. Strubin, M., Berte, C., Mach, B. (1986) Alternative splicing and alternative initiation of translation explain the four forms of the Ia antigen-associated invariant chain. EMBOJ. 5, 3483-3488.
19. Strubin, M., Long, E. O., Mach, B. (1986) Two forms of the Ia antigen-associated invariant chain result from alternative initiations at two in-phase AUGs. Cell 47, 619-625.
20. Hsing, L. C, Rudensky, A. Y. (2005) The lysosomal cysteine proteases in MHC class II antigen presentation. Immunol. Rev. 207, 229-241.
21. Watts, C. (2004) The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules. Nat. Immunol. 5, 685-692.
22. Vascotto, F., Lankar, D., FaureAndre, G, Vargas, P., Diaz, J., Le Roux, D., Yuseff, M. I., Sibarita, J. B., Boes, M., Raposo, G, Mougneau, E., Glaichenhaus, N., Bonnerot, C, Manoury, B., Lennon-Dumenil, A M. (2007) The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation. J. Cell Biol. 176, 1007-1019.
23. Landsverk, O. J., Barois, N., Gregers, T. F., Bakke, O. (2011) Invariant chain increases the half-life of MHC II by delaying endosomal maturation. Immunol. Cell Biol 89, 619-629.
24. Ogrinc, T., Dolenc, I., Ritonja, A, Turk, V. (1993) Purification of the complex of cathepsin L and the MHC class II-associated invariant chain fragment from human kidney. FEBS Lett. 336, 555-559.
25. Bevec, T, Stoka, V., Pungercic, G., Dolenc, I., Turk, V. (1996) Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L.J. Exp. Med 183, 1331-1338.
26. Mihelic, M., Dobersek, A, Guncar, G., Turk, D. (2008) Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine cathepsins in antigen presentation. J. Biol. Chem. 283, 14453-14460.
27. Fineschi, B., Sakaguchi, K, Appella, E., Miller, J. (1996) The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain.J. Immunol. 157, 3211-3215.
28. Lennon-Dumenil, A. M., Roberts, R A, Valentijn, K., Driessen, C, Overk-leeft, H. S., Erickson, A, Peters, P. J., Bikoff, E., Ploegh, H. L., Wolf Bryant, P. (2001) The p41 isoform of invariant chain is a chaperone for cathepsin L. EMBOJ. 20, 4055-4064.
29. Faure-Andre, G., Vargas, P., Yuseff, M. I., Heuze, M., Diaz, J., Lankar, D., Steri, V., Manry, J., Hugues, S., Vascotto, F., Boulanger, J., Raposo, G., Bono, M. R, Rosemblatt, M., Piel, M., Lennon-Dumenil, A. M. (2008) Regulation of dendritic cell migration by CD74, the MHC class II-associated invariant chain. Science 322, 1705-1710.
30. Sallusto, F., Lanzavecchia, A. (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor a. J. Exp. Med. 179, 1109-1118.
31. Khalil, H., Brunet, A, Saba, I., Terra, R, Sekaly, R P., Thibodeau, J. (2003) The MHC class II /3 chain cytoplasmic tail overcomes the invariant chain p35-encoded endoplasmic reticulum retention signal. Int. Immunol. 15, 1249-1263.
32. Khalil, H., Brunet, A, Thibodeau, J. (2005) A three-amino-acid-long HLA-DR/3 cytoplasmic tail is sufficient to overcome ER retention of invariant-chain p35. J. Cell Sci. 118, 4679-4687.
33. Jonuleit, H., Kuhn, U., Muller, G., Steinbrink, K, Paragnik, L., Schmitt, E., Knop, J., Enk, A. H. (1997) Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 27, 3135-3142.
34. Landsverk, O. J., Bakke, O., Gregers, T F. (2009) MHC II and the endocytic pathway: regulation by invariant chain. Scand J. Immunol. 70, 184-193.
35. Leng, L., Metz, C. N., Fang, Y, Xu, J., Donnelly, S., Baugh, J., Delohery, T., Chen, Y, Mitchell, R A, Bucala, R. (2003) MIF signal transduction initiated by binding to CD74. J. Exp. Med. 197, 1467-1476.
36. Sloma, I., Zilber, M. T., Vasselon, T., Setterblad, N., Cavallari, M., Mori, L., De Libero, G., Charron, D., Mooney, N., Gelin, C. (2008) Regulation of CD1a surface expression and antigen presentation by invariant chain and lipid rafts. J. Immunol. 180, 980-987.
37. Jayawardena-Wolf, J., Benlagha, K, Chiu, Y H., Mehr, R, Bendelac, A. (2001) CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity 15, 897-908.
38. Ye, L., Liu, X., Rout, S. N., Li, Z., Yan, Y, Lu, L., Kamala, T., Nanda, N. K, Song, W., Samal, S. K, Zhu, X. (2008) The MHC class II-associated invariant chain interacts with the neonatal Fc 7 receptor and modulates its trafficking to endosomal/lysosomal compartments. J. Immunol. 181, 2572-2585.
39. Young, L. J., Wilson, N. S., Schnorrer, P., Mount, A, Lundie, R. J., La Gruta, N. L., Crabb, B. S., Belz, G. T., Heath, W. R, Villadangos, J. A. (2007) Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens. Proc. Natl. Acad. Sci. USA 104, 17753-17758.
40. Reith, W., LeibundGut-Landmann, S., Waldburger, J. M. (2005) Regulation of MHC class II gene expression by the class II transactivator. Nat. Rev. Immunol. 5, 793-806.
41. Krawczyk, M., Peyraud, N., Rybtsova, N., Masternak, K, Bucher, P., Barras, E., Reith, W. (2004) Long distance control of MHC class II expression by multiple distal enhancers regulated by regulatory factor X complex and CIITAJ. Immunol. 173, 6200-6210.
42. Moore, B. B., Cao, Z. A, McRae, T. L., Woo, C. H., Conley, S., Jones, P. P. (1998) The invariant chain gene intronic enhancer shows homology to class II promoter elements.J. Immunol. 161, 1844-1852.
43. Zhu, L., Jones, P. P. (1990) Transcriptional control of the invariant chain gene involves promoter and enhancer elements common to and distinct from major histocompatibility complex class II genes. Mol. Cell. Biol. 10, 3906-3916.
44. Shih, N. Y, Soesilo, I., Floyd-Smith, G. (1997) Stabilization of invariant chain mRNA by 12-O-tetradecanoylphorbol-13-acetate is blocked by IFN-7 in a murine B lymphoma cell line. J Interferon Cytokine Res. 17, 747-755.
45. Shih, N-Y, Floyd-Smith, G. (1995) Invariant chain (CD74) gene regulation: enhanced expression associated with activation of protein kinase C5 in a murine B lymphoma cell line. Mol. Immunol. 32, 643-650.
46. Asirvatham, A. J., Gregorie, C. J., Hu, Z., Magner, W. J., Tomasi, T. B. (2008) MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components. Mol. Immunol. 45, 1995-2006.
47. De Gassart, A, Camosseto, V, Thibodeau, J., Ceppi, M., Catalan, N., Pierre, P., Gatti, E. (2008) MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation. Proc. Natl. Acad. Sci. USA 105, 3491-3496.
48. Walseng, E., Furuta, K, Bosch, B., Weih, K. A, Matsuki, Y, Bakke, O., Ishido, S., Roche, P. A. (2010) Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells. Proc. Natl. Acad. Sci. USA 107, 20465-21470.
49. Walseng, E., Furuta, K, Goldszmid, R S., Weih, K. A, Sher, A, Roche, P. A. (2010) Dendritic cell activation prevents MHC class II ubiquitination and promotes MHC class II survival regardless of the activation stimulus. J. Biol. Chem. 285, 41749-41754.
50. Lotteau, V, Teyton, L., Peleraux, A, Nilsson, T., Karlsson, L., Schmid, S. L., Quaranta, V., Peterson, P. A. (1990) Intracellular transport of class II MHC molecules directed by invariant chain. Nature 348, 600-605.
51. Lamb, C. A, Yewdell, J. W., Bennink, J. R., Cresswell, P. (1991) Invariant chain targets HLA class II molecules to acidic endosomes containing internalized influenza virus. Proc. Natl. Acad. Sci. USA 88, 5998-6002.
52. Arunachalam, B., Lamb, C. A., Cresswell, P. (1994) Transport properties of free and MHC class II-associated oligomers containing different isoforms of human invariant chain. Int. Immunol. 6, 439-451.
53. Anderson, H. A, Bergstralh, D. T., Kawamura, T., Blauvelt, A, Roche, P. A. (1999) Phosphorylation of the invariant chain by protein kinase C regulates MHC class II trafficking to antigen-processing compartments. J. Immunol. 163, 5435-5443.
54. Kuwana, T., Peterson, P. A, Karlsson, L. (1998) Exit of major histocompatibility complex class II-invariant chain p35 complexes from the endoplasmic reticulum is modulated by phosphorylation. Proc. Natl. Acad. Sci. USA 95, 1056-1061.
55. O'Kelly, I., Butler, M. H., Zilberberg, N., Goldstein, S. A. (2002) Forward transport. 14-3-3 binding overcomes retention in endoplasmic reticulum by dibasic signals. Cell 111, 577-588.
56. Young, L. J., Wilson, N. S., Schnorrer, P., Proietto, A, ten Broeke, T., Matsuki, Y, Mount, A. M., Belz, G. T., O'Keeffe, M., Ohmura-Hoshino, M., Ishido, S., Stoorvogel, W., Heath, W. R, Shortman, K, Villadangos, J. A. (2008) Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells. Nat Immunol. 9, 1244-1252.